星空体育官方入口网站网址大全-登录入口官网

Phase 2 trial of tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208).

Mahdi, H; Schuster, SR; O'Malley, DM; McNamara, DM; Rangwala, RA; Liang, SY; Jain, S; Nicacio, L; Chon, HS